Skip to main content
. 2021 Mar 8;14(1):neurintsurg-2020-017050. doi: 10.1136/neurintsurg-2020-017050

Table 3.

Repeated imaging findings

Imaging modality All patients (n=165) Clinical improvement* (n=86) Clinical deterioration† (n=40)
NCCT‡
 Symptomatic ICH 0/120 (0%) 0/50 (0%) 0/38 (0%)
 Asymptomatic ICH 1/120 (1%) 0/50 (0%) 0/38 (0%)
CTA§
 Persistent LVO 67/124 (54%) 36/86 (42%) 10/13 (77%)
  Same segment 55/124 (44%) 28/86 (33%) 8/13 (62%)
  Distal migration 11/124 (9%) 8/86 (9%) 2/13 (15%)
  New vascular territory 1/124 (1%) 0/86 (0%) 0/13 (0%)
 LVO resolved 57/124 (46%) 50/86 (58%) 3/13 (23%)

*Median Δ NIHSS score between PSC and CSC: −5 (−8 to −2).

†Median Δ NIHSS score between PSC and CSC: 6 (3 to 9).

‡NCCT was repeated in 120/165 patients (73%); 50/86 (58%) of patients with clinical improvement and 38/40 (95%) of patients with clinical deterioration.

§CTA was repeated in 124/165 patients (75%); all patients with clinical improvement and 13/40 (33%) of patients with clinical deterioration.

CSC, comprehensive stroke center; CTA, CT angiography; ICH, intracranial hemorrhage; LVO, large vessel occlusion; NCCT, non-contrast CT; PSC, primary stroke center.